Tag Archives: RBC

Encana Corp. downgraded at RBC


Encana Corp. was downgraded to sector perform from outperform at RBC Capital Markets, however the outlook isn’t everything bad. Analyst Greg Pardy, who also raised his price target on the stock to US$15 from US$14, noted that the Canadian energy producer has successfully refocused its portfolio for high-margin growth for the foreseeable future. However, he thinks the company’s next goal ...

Read More »

Goldcorp Inc’s dividend requires better execution – RBC


Goldcorp Inc. was hit having a downgrade at RBC Capital Markets because the miner’s disappointing results are raising concerns concerning the sustainability of their dividend. Analyst Stephen Walker told clients that investors will likely take a show-me approach around the stock since Goldcorp has failed to meet its guidance on several occasions. He thinks the organization will need to successfully ...

Read More »

Newmont Mining Corp. upgraded at RBC


Newmont Mining Corp. was upgraded to outperform from sector perform at RBC Capital Markets due to improvements in the operating momentum and the disappearance of an M&A-related overhang. The Colorado-based miner acquired the Cripple Creek & Victor gold mine from AngloGold Ashanti Ltd. for US$820 million in cash earlier this week. The deal is accretive for Newmont, nevertheless its share ...

Read More »

Is RBC the next too-big-to-fail global bank?


Royal Bank of Canada may be the first Canadian bank included around the Bank of International Settlements’ list of too-big-to-fail global financial institutions based on its 2014 year-end balance sheet. The listing of Globally Systemically Important Banks (G-SIB) was first unveiled in 2011 and is largely based on a bank’s size and inter-connectedness, which triggers higher capital requirements. Canaccord Genuity ...

Read More »

Valeant passes RBC as Canada’s largest company by market value


Valeant Pharmaceuticals International Inc., the drugs company on an acquisition streak, surpassed Royal Bank of Canada because the country\’s largest company by market price on the Toronto Stock market. Valeant surged 4.5 percent to $326.10 per share for any market value of $111.3 billion (US$85.7 billion) at 11:21 a.m. in Toronto. That eclipsed Royal Bank\’s $108.3 billion market price, according ...

Read More »

Valeant Pharmaceuticals International Inc topples RBC to emerge as Canada’s most valuable company


MONTREAL – Valeant Pharmaceuticals International Inc. has surpassed Royal Bank of Canada as the country\’s largest company by market price after shares increased in the wake of solid second quarter results. Valeant surged a lot more than nine per cent to a 52-week-high of $341.02 per share to achieve a market worth of $116.3 billion around the Toronto Stock Exchange, ...

Read More »